Advanced search

Vol 79, Supp. III (2021): Zeszyty Edukacyjne 3/2021
Opinie i stanowiska ekspertów
Published online: 2021-09-16

open access

View PDF (Polish) Download PDF file View HTML (Polish)
Page views 3231
Article views/downloads 4422
Get Citation

Connect on Social Media

Connect on Social Media

Kompleksowa rehabilitacja kardiologiczna podstawą prewencji wtórnej chorób układu sercowo-naczyniowego. Opinia ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego

Anna Jegier1, Dominika Szalewska2, Agnieszka Mawlichanów3, Tadeusz Bednarczyk4, Zbigniew Eysymontt5, Michał Gałaszek5, Artur Mamcarz6, Anna Mierzyńska78, Ewa Piotrowicz9, Ryszard Piotrowicz710, Krzysztof Smarż11, Edyta Smolis-Bąk7, Ewa Straburzyńska-Migaj12, Jadwiga Wolszakiewicz7
DOI: 10.33963/v.kp.85931

Abstract

Kompleksowa rehabilitacja kardiologiczna (CR) jest podstawą wtórnej prewencji chorób układu sercowo-naczyniowego (CVD). W wytycznych Europejskiego Towarzystwa Kardiologicznego CR ma najwyższą klasę zaleceń i najwyższy poziom wiarygodności danych naukowych jako skuteczna metoda leczenia chorych z zawałem serca z uniesieniem odcinka ST, po rewaskularyzacji mięśnia sercowego, z przewlekłym zespołem wieńcowym, stosowana w profilaktyce CVD w praktyce klinicznej oraz u osób z niewydolnością serca. Niniejszy dokument przedstawia opinię ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego dotyczącą korzyści z CR, grup docelowych, wskazań klinicznych, organizacji świadczeń rehabilitacyjnych i sposobów ich realizacji. W opracowaniu przedstawiono również psychospołeczne czynniki ryzyka wpływające na przebieg CR oraz prewencję wtórną CVD u chorych poddawanych CR. Kompleksowa CR to proces, który powinien zostać wdrożony jak najszybciej, być kontynuowany bez przerwy i składać się z wielu etapów. Ponadto CR powinna być dostosowana do indywidualnej sytuacji klinicznej i akceptowana przez chorego oraz jego rodzinę, przyjaciół i opiekunów.

Keywords: opinia ekspertówrehabilitacja kardiologicznachoroby układu sercowo-naczyniowegoprewencja wtórna CVD

Full content:

View HTML (Polish) View PDF (Polish) Download PDF file

References

  1. Ibanez B, James S, Agewall S, et al. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018; 39(2): 119–177.
    CrossRefPubMed
  2. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J. 2019; 40(2): 87–165.
    CrossRefPubMed
  3. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
    CrossRefPubMed
  4. Piepoli MF, Hoes AW, Agewall S, et al. ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016; 37(29): 2315–2381.
    CrossRefPubMed
  5. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Committee for Practice Guidelines (CPG). ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail. 2008; 10(10): 933–989.
    CrossRefPubMed
  6. Ponikowski P, Voors AA, Anker SD, et al. ESC Scientific Document Group. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129–2200.
    CrossRefPubMed
  7. Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(10): 1169–1186.
    CrossRefPubMed
  8. Pelliccia A, Sharma S, Gati S, et al. ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021; 42(1): 17–96.
    CrossRefPubMed
  9. Haykowsky M, Scott J, Esch B, et al. A meta-analysis of the effects of exercise training on left ventricular remodeling following myocardial infarction: start early and go longer for greatest exercise benefits on remodeling. Trials. 2011; 12: 92.
    CrossRefPubMed
  10. Cowie A, Buckley J, Doherty P, et al. British Association for Cardiovascular Prevention and Rehabilitation (BACPR). Standards and core components for cardiovascular disease prevention and rehabilitation. Heart. 2019; 105(7): 510–515.
    CrossRefPubMed
  11. Ambrosetti M, Abreu A, Corrà U, et al. Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology. Eur J Prev Cardiol. 2020 [Epub ahead of print]: 2047487320913379.
    CrossRefPubMed
  12. Abreu A, Schmidt JP, Piepoli ME. ESC Handbook of cardiovascular rehabilitation: a practical clinical guide. Oxford University Press. 2020.
    CrossRef
  13. Piotrowicz R, Jegier A, Szalewska D. Rekomendacje w zakresie realizacji kompleksowej rehabilitacji kardiologicznej. Stanowisko Ekspertów Sekcji Rehabilitacji Kardiologicznej i Fizjologii Wysiłku Polskiego Towarzystwa Kardiologicznego. AsteriaMed, Gdańsk 2017.
  14. Alter DA, Oh PI, Chong A. Relationship between cardiac rehabilitation and survival after acute cardiac hospitalization within a universal health care system. Eur J Cardiovasc Prev Rehabil. 2009; 16(1): 102–113.
    CrossRefPubMed
  15. Rauch B, Davos CH, Doherty P, et al. ‘Cardiac Rehabilitation Section’, European Association of Preventive Cardiology (EAPC), in cooperation with the Institute of Medical Biometry and Informatics (IMBI), Department of Medical Biometry, University of Heidelberg, and the Cochrane Metabolic and Endocrine Disorders Group, Institute of General Practice, Heinrich-Heine University, Düsseldorf, Germany. The prognostic effect of cardiac rehabilitation in the era of acute revascularisation and statin therapy: A systematic review and meta-analysis of randomized and non-randomized studies — The Cardiac Rehabilitation Outcome Study (CROS). Eur J Prev Cardiol. 2016; 23(18): 1914–1939.
    CrossRefPubMed
  16. Smarż K, Jaxa-Chamiec T, Bednarczyk T, et al. Electrocardiographic exercise testing in adults: performance and interpretation. An expert opinion of the Polish Cardiac Society Working Group on Cardiac Rehabilitation and Exercise Physiology. Kardiol Pol. 2019; 77(3): 399–408.
    CrossRefPubMed
  17. Smarż K, Jaxa-Chamiec T, Chwyczko T, et al. Cardiopulmonary exercise testing in adult cardiology: expert opinion of the Working Group of Cardiac Rehabilitation and Exercise Physiology of the Polish Cardiac Society. Kardiol Pol. 2019; 77(7-8): 730–756.
    CrossRefPubMed
  18. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166(1): 111–117.
    CrossRefPubMed
  19. Steinberg JS, Varma N, Cygankiewicz I, et al. 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/telemetry. Ann Noninvasive Electrocardiol. 2017; 22(3): e12447.
    CrossRefPubMed
  20. Lipiec P, Bąk J, Braksator W, et al. Transthoracic echocardiography in adults — guidelines of the Working Group on Echocardiography of the Polish Cardiac Society [article in Polish]. Kardiol Pol. 2018; 76(2): 488–493.
    CrossRefPubMed
  21. Steeds RP, Garbi M, Cardim N, et al. 2014–2016 EACVI Scientific Documents Committee. EACVI appropriateness criteria for the use of transthoracic echocardiography in adults: a report of literature and current practice review. Eur Heart J Cardiovasc Imaging. 2017; 18(11): 1191–1204.
    CrossRefPubMed
  22. Gielen S, Laughlin MH, O'Conner C, et al. Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations. Prog Cardiovasc Dis. 2015; 57(4): 347–355.
    CrossRefPubMed
  23. Smolis-Bak E, Kazimierska B. Fizjoterapia w kardiologii. Lapisart, Warszawa 2013.
  24. Piotrowicz R, Piotrowicz E. Telerehabilitacja. Tekst sp. z o.o., Warszawa 2011.
  25. Piotrowicz E. How to do: telerehabilitation in heart failure patients. Cardiol J. 2012; 19(3): 243–248.
    CrossRefPubMed
  26. Piotrowicz E, Piepoli MF, Jaarsma T, et al. Telerehabilitation in heart failure patients: The evidence and the pitfalls. Int J Cardiol. 2016; 220: 408–413.
    CrossRefPubMed
  27. Piotrowicz E, Pencina MJ, Opolski G, et al. Effects of a 9-week hybrid comprehensive telerehabilitation program on long-term outcomes in patients with heart failure: the telerehabilitation in heart failure patients (TELEREH-HF) randomized clinical trial. JAMA Cardiol. 2020; 5(3): 300–308.
    CrossRefPubMed
  28. Piotrowicz E, Baranowski R, Bilinska M, et al. A new model of home-based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. Eur J Heart Fail. 2010; 12(2): 164–171.
    CrossRefPubMed
  29. Piotrowicz E, Zieliński T, Bodalski R, et al. Home-based telemonitored nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study. Eur J Prev Cardiol. 2015; 22(11): 1368–1377.
    CrossRefPubMed
  30. Piotrowicz E, Korzeniowska-Kubacka I, Chrapowicka A, et al. Feasibility of home-based cardiac telerehabilitation: results of TeleInterMed study. Cardiol J. 2014; 21(5): 539–546.
    CrossRefPubMed
  31. Piotrowicz R, Krzesiński P, Balsam P, et al. Cardiology telemedicine solutions — opinion of the experts of the Committee of Informatics and Telemedicine of Polish Society of Cardiology, Section of Non-invasive Electrocardiology and Telemedicine of Polish Society of Cardiology and Clinical Sciences C [article in Polish]. Kardiol Pol. 2018; 76(3): 698–707.
    CrossRefPubMed
  32. Jankowski P, Niewada M, Bochenek A, et al. Optimal model of comprehensive rehabilitation and secondary prevention [article in Polish]. Kardiol Pol. 2013; 71(9): 995–1003.
    CrossRefPubMed
  33. Rozporządzenie ministra zdrowia z dnia 16 grudnia 2016 r. zmieniające rozporządzenie w sprawie świadczeń gwarantowanych z zakresu rehabilitacji leczniczej. Dz. U. 2016, poz. 2162.
  34. Jankowski P, Gąsior M, Gierlotka M, et al. Coordinated care after myocardial infarction. The statement of the Polish Cardiac Society and the Agency for Health Technology Assessment and Tariff System [article in Polish]. Kardiol Pol. 2016; 74(8): 800–811.
    CrossRefPubMed
  35. Anderson L, Thompson DR, Oldridge N, et al. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2016; 67(1): CD001800.
    CrossRefPubMed
  36. de Vries H, Kemps HMC, van Engen-Verheul MM, et al. Cardiac rehabilitation and survival in a large representative community cohort of Dutch patients. Eur Heart J. 2015; 36(24): 1519–1528.
    CrossRefPubMed
  37. Ponikowski P, Voors AA, Anker SD, et al. Authors/Task Force Members, Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016; 18(8): 891–975.
    CrossRefPubMed
  38. Fletcher GF, Ades PA, Kligfield P, et al. American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013; 128(8): 873–934.
    CrossRefPubMed
  39. Piepoli MF, Conraads V, Corrà U, et al. Exercise training in heart failure: from theory to practice. A consensus document of the Heart Failure Association and the European Association for Cardiovascular Prevention and Rehabilitation. Eur J Heart Fail. 2011; 13(4): 347–357.
    CrossRefPubMed
  40. Mezzani A, Hamm LF, Jones AM, et al. European Association for Cardiovascular Prevention and Rehabilitation, American Association of Cardiovascular and Pulmonary Rehabilitation, Canadian Association of Cardiac Rehabilitation. Aerobic exercise intensity assessment and prescription in cardiac rehabilitation: a joint position statement of the European Association for Cardiovascular Prevention and Rehabilitation, the American Association of Cardiovascular and Pulmonary Rehabilitation and the Canadian Association of Cardiac Rehabilitation. Eur J Prev Cardiol. 2013; 20(3): 442–467.
    CrossRefPubMed
  41. Adamopoulos S, Corrà U, Laoutaris ID, et al. Exercise training in patients with ventricular assist devices: a review of the evidence and practical advice. A position paper from the Committee on Exercise Physiology and Training and the Committee of Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019; 21(1): 3–13.
    CrossRefPubMed
  42. Potapov EV, Antonides C, Crespo-Leiro MG, et al. 2019 EACTS Expert Consensus on long-term mechanical circulatory support. Eur J Cardiothorac Surg. 2019; 56(2): 230–270.
    CrossRefPubMed
  43. Kindermann M, Schwaab B, Finkler N, et al. Defining the optimum upper heart rate limit during exercise: a study in pacemaker patients with heart failure. Eur Heart J. 2002; 23(16): 1301–1308.
    CrossRefPubMed
  44. Abreu A, Frederix I, Dendale P, et al. Secondary Prevention and Rehabilitation Section of EAPC, Secondary Prevention and Rehabilitation Section of EAPC Reviewers: Marco Ambrosetti. Standardization and quality improvement of secondary prevention through cardiovascular rehabilitation programmes in Europe: The avenue towards EAPC accreditation programme: A position statement of the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology (EAPC). Eur J Prev Cardiol. 2020 [Epub ahead of print]: 2047487320924912.
    CrossRefPubMed
  45. Caimmi PP, Sabbatini M, Kapetanakis EI, et al. A randomized trial to assess the contribution of a novel thorax support vest (corset) in preventing mechanical complications of median sternotomy. Cardiol Ther. 2017; 6(1): 41–51.
    CrossRefPubMed
  46. Sibilitz KL, Berg SK, Tang LH, et al. Exercise-based cardiac rehabilitation for adults after heart valve surgery. Cochrane Database Syst Rev. 2016; 3: CD010876.
    CrossRefPubMed
  47. Ribeiro GS, Melo RD, Deresz LF, et al. Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement: Systematic review and meta-analysis. Eur J Prev Cardiol. 2017; 24(7): 688–697.
    CrossRefPubMed
  48. Piepoli MF, Corrà U, Benzer W, et al. Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil. 2010; 17(1): 1–17.
    CrossRefPubMed
  49. Kuch M, Janiszewski M, Mamcarz A. Rehabilitacja kardiologiczna. Medical Education, Warszawa 2014.
  50. Anderson L, Nguyen TT, Dall CH, et al. Exercise-based cardiac rehabilitation in heart transplant recipients. Cochrane Database Syst Rev. 2017; 4: CD012264.
    CrossRefPubMed
  51. DuBois CM, Lopez OV, Beale EE, et al. Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: a systematic review. Int J Cardiol. 2015; 195: 265–280.
    CrossRefPubMed
  52. Ladwig KH, Lederbogen F, Albus C, et al. Position paper on the importance of psychosocial factors in cardiology: update 2013. Ger Med Sci. 2014; 12: Doc09.
    CrossRefPubMed
  53. Pogosova N, Saner H, Pedersen SS, et al. Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol. 2015; 22(10): 1290–1306.
    CrossRefPubMed
  54. Mierzyńska A, Kowalska M, Stepnowska M, et al. Psychological support for patients following myocardial infarction. Cardiol J. 2010; 17(3): 319–324.
    PubMed
  55. Beniamini Y, Johnston M, Karademas EC. Assessment in health psychology. Hogrefe Publishing GmbH, Göttingen 2016.
  56. Diener E, Emmons RA, Larson RJ, Griffin S. Skala satysfakcji z życia SWLS. In: Juczyński Z. ed. Narzędzia do pomiaru w promocji i psychologii zdrowia. Pracownia Testów Psychologicznych PTP, Warszawa 2001: 134–138.
  57. Golicki D, Niewada M. EQ-5D-5L Polish population norms. Arch Med Sci. 2017; 13(1): 191–200.
    CrossRefPubMed
  58. Höfer S, Lim L, Guyatt G, et al. The MacNew heart disease health-related quality of life instrument: a summary. Health Qual Life Outcomes. 2004; 2: 3.
    CrossRefPubMed
  59. Kokoszka A, Jastrzębski A, Obrębski M. Psychometric properties of the polish version of Patient Health Questionnaire-9 [article in Polish]. Psychiatria. 2016; 13(4): 187–193.
  60. Łojek E, Wójcik E, Stańczak J. Kwestionariusz do pomiaru depresji. Podręcznik. Pracownia Testów Psychologicznych PTP, Warszawa 2015.
  61. Makowska Z, Merecz D. Ocena zdrowia psychicznego na podstawie badań kwestionariuszami Davida Goldberga. Wydawnictwo Instytutu Medycyny Pracy, Łódź 2001.
  62. Locke AB, Kirst N, Shultz CG. Diagnosis and management of generalized anxiety disorder and panic disorder in adults. Am Fam Physician. 2015; 91(9): 617–624.
    PubMed
  63. Juczyński Z, Ogińska-Bulik N. Narzędzia pomiaru stresu i radzenia sobie ze stresem. Pracownia Testów Psychologicznych PTP, Warszawa 2010.
  64. Strelau J, Jaworowska A, Wrześniewski K, Szczepaniak P. Kwestionariusz radzenia sobie w sytuacjach stresowych CISS. Podręcznik. Pracownia Testów Psychologicznych PTP, Warszawa 2005.
  65. Uchmanowicz I, Wleklik M. Polish adaptation and reliability testing of the nine-item European Heart Failure Self-care Behaviour Scale (9-EHFScBS). Kardiol Pol. 2016; 74(7): 691–696.
    CrossRefPubMed
  66. Moon SJ, Lee WY, Hwang JS, et al. Accuracy of a screening tool for medication adherence: A systematic review and meta-analysis of the Morisky Medication Adherence Scale-8. PLoS One. 2017; 12(11): e0187139.
    CrossRefPubMed
  67. Pogosova N, Kotseva K, De Bacquer D, et al. EUROASPIRE Investigators. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. Eur J Prev Cardiol. 2017; 24(13): 1371–1380.
    CrossRefPubMed
  68. Mierzyńska A, Jurczak K, Piotrowicz R. Psychological interventions in cardiology — short-term motivational strategies. Archives of Psychiatry and Psychotherapy. 2017; 19(2): 15–24.
    CrossRef
  69. Lichtman JH, Bigger JT, Blumenthal JA, et al. American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, American Heart Association Council on Clinical Cardiology, American Heart Association Council on Epidemiology and Prevention, American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, American Psychiatric Association. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation. 2008; 118(17): 1768–1775.
    CrossRefPubMed
  70. Piepoli MF, Abreu A, Albus C, et al. Update on cardiovascular prevention in clinical practice: A position paper of the European Association of Preventive Cardiology of the European Society of Cardiology. Eur J Prev Cardiol. 2020; 27(2): 181–205.
    CrossRefPubMed
  71. Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020; 41(3): 407–477.
    CrossRefPubMed
  72. Mach F, Baigent C, Catapano AL, et al. ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020; 41(1): 111–188.
    CrossRefPubMed
  73. Nissen SE, Nicholls SJ, Sipahi I, et al. ASTEROID Investigators. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA. 2006; 295(13): 1556–1565.
    CrossRefPubMed
  74. Cannon CP, Blazing MA, Giugliano RP, et al. IMPROVE-IT Investigators. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015; 372(25): 2387–2397.
    CrossRefPubMed
  75. Sabatine MS, Giugliano RP, Keech AC, et al. FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med. 2017; 376(18): 1713–1722.
    CrossRefPubMed
  76. Schwartz GG, Steg PG, Szarek M, et al. ODYSSEY OUTCOMES Committees and Investigators. Alirocumab and cardiovascular outcomes after acute coronary syndrome. N Engl J Med. 2018; 379(22): 2097–2107.
    CrossRefPubMed
  77. Berrington de Gonzalez A, Hartge P, Cerhan JR, et al. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010; 363(23): 2211–2219.
    CrossRefPubMed
  78. Wormser D, Kaptoge S, Di Angelantonio EE, et al. Emerging Risk Factors Collaboration. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011; 377(9771): 1085–1095.
    CrossRefPubMed
  79. Wolfe BM, Kvach E, Eckel RH. Treatment of obesity: weight loss and bariatric surgery. Circ Res. 2016; 118(11): 1844–1855.
    CrossRefPubMed
  80. O'Neil P, Birkenfeld A, McGowan B, et al. Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial. The Lancet. 2018; 392(10148): 637–649.
    CrossRefPubMed
  81. Mirabelli M, Chiefari E, Caroleo P, et al. Long-term effectiveness of liraglutide for weight management and glycemic control in type 2 diabetes. Int J Environ Res Public Health. 2019; 17(1): 207.
    CrossRefPubMed
  82. Williams B, Mancia G, Spiering W, et al. ESC Scientific Document Group. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J. 2018; 39(33): 3021–3104.
    CrossRefPubMed
  83. Zinman B, Wanner C, Lachin JM, et al. EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015; 373(22): 2117–2128.
    CrossRefPubMed
  84. Wiviott SD, Raz I, Bonaca MP, et al. DECLARE–TIMI 58 Investigators. Dapagliflozin and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2019; 380(4): 347–357.
    CrossRefPubMed
  85. Marso SP, Daniels GH, Brown-Frandsen K, et al. LEADER Steering Committee, LEADER Trial Investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016; 375(4): 311–322.
    CrossRefPubMed
  86. Husain M, Birkenfeld AL, Donsmark M, et al. PIONEER 6 Investigators. Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2019; 381(9): 841–851.
    CrossRefPubMed
  87. Zelniker TA, Wiviott SD, Raz I, et al. Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus. Circulation. 2019; 139(17): 2022–2031.
    CrossRefPubMed
  88. Cosentino F, Grant PJ, Aboyans V, et al. ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J. 2020; 41(2): 255–323.
    CrossRefPubMed
  89. Chow CK, Jolly S, Rao-Melacini P, et al. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010; 121(6): 750–758.
    CrossRefPubMed
  90. Cahill K, Stevens S, Perera R, et al. Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database Syst Rev. 2013(5): CD009329.
    CrossRefPubMed
  91. Malas M, van der Tempel J, Schwartz R, et al. Electronic cigarettes for smoking cessation: a systematic review. Nicotine Tob Res. 2016; 18(10): 1926–1936.
    CrossRefPubMed
  92. Ghosh S, Drummond MB. Electronic cigarettes as smoking cessation tool: are we there? Curr Opin Pulm Med. 2017; 23(2): 111–116.
    CrossRefPubMed
  93. Law MR, Morris JK, Wald NJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ. 1997; 315(7114): 973–980.
    CrossRefPubMed
  94. DiGiacomo SI, Jazayeri MA, Barua RS, et al. Environmental tobacco smoke and cardiovascular disease. Int J Environ Res Public Health. 2018; 16(1): 96.
    CrossRefPubMed
  95. Clinical Practice Guideline Treating Tobacco Use and Dependence 2008 Update Panel, Liaisons, and Staff. A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. Am J Prev Med. 2008; 35(2): 158–176.
    CrossRefPubMed
  96. Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018; 72(25): 3332–3365.
    CrossRefPubMed
  97. Samitz G, Egger M, Zwahlen M. Domains of physical activity and all-cause mortality: systematic review and dose-response meta-analysis of cohort studies. Int J Epidemiol. 2011; 40(5): 1382–1400.
    CrossRefPubMed
  98. Talbot LA, Morrell CH, Fleg JL, et al. Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging. Prev Med. 2007; 45(2-3): 169–176.
    CrossRefPubMed
  99. Piepoli MF, Davos C, Francis DP, et al. ExTraMATCH Collaborative. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ. 2004; 328(7433): 189.
    CrossRefPubMed
  100. Young DR, Hivert MF, Alhassan S, et al. Physical Activity Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Stroke Council. Sedentary behavior and cardiovascular morbidity and mortality: a science advisory from the American Heart Association. Circulation. 2016; 134(13): e262–e279.
    CrossRefPubMed
  101. Fletcher GF, Ades PA, Kligfield P, et al. American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology, Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular and Stroke Nursing, and Council on Epidemiology and Prevention. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation. 2013; 128(8): 873–934.
    CrossRefPubMed
  102. Bruning RS, Sturek M. Benefits of exercise training on coronary blood flow in coronary artery disease patients. Prog Cardiovasc Dis. 2015; 57(5): 443–453.
    CrossRefPubMed
  103. Huffman JC, Niazi SK, Rundell JR, et al. Essential articles on collaborative care models for the treatment of psychiatric disorders in medical settings: a publication by the academy of psychosomatic medicine research and evidence-based practice committee. Psychosomatics. 2014; 55(2): 109–122.
    CrossRefPubMed
  104. Bishop GD, Kaur D, Tan VLM, et al. Effects of a psychosocial skills training workshop on psychophysiological and psychosocial risk in patients undergoing coronary artery bypass grafting. Am Heart J. 2005; 150(3): 602–609.
    CrossRefPubMed

About cookies

Necessary cookies

Allways active

These cookies are necessary for the proper display and operation of the website. Blocking them may cause the website to malfunction.

Analytical cookies

As part of our website, we use analytical tools, such as Google Analytics, that allow us to verify website traffic. These tools may require the use of cookies.

Community cookies

These are cookies associated with the social networks we use. Accepting them will allow us to associate your visit to the site with our social media profiles.

Marketing cookies

These are cookies responsible for carrying out advertising and marketing activities - consenting to their use will allow us to target you with advertisements based on your previous activities within our website.

Copyright © 2023-2024 Via Medica Regulations Cookie policy Privacy Statement Legal Note